Myeloma Crowd Radio

Myeloma Crowd Radio brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.



      episode 12: Myeloma Crowd Radio: Ashraf Badros, MD, University of Maryland

      Let's talk about multiple myeloma in the African American community



      episode 11: Myeloma Crowd: Irene Ghobrial, MD, Dana Farber Cancer Institute

      A 50,000 patient and family study for early precursor myeloma conditions



      episode 10: Myeloma Crowd Radio: Maria Chaudhry, MD, Ohio State University

      Learn more about the new GSK antibody for relapsed/refractory multiple myeloma


       2018-09-13  1h0m

      episode 9: Myeloma Crowd: Paul Richardson, MD, Dana Farber Cancer Institute

      Mid-Year Review for Multiple Myeloma


       2018-08-03  1h28m

      episode 8: Myeloma Crowd Radio: Brian McMahon of SparkCures (rescheduled)

      How to get into popular myeloma clinical trials


       2018-07-30  1h14m

      episode 6: Myeloma Crowd Radio: Muhamed Baljevic, MD, University of Nebraska Medical Center

      Many myeloma patients can become resistant to an important class of myeloma drugs called proteasome inhibitors. Here's a new drug that may help overcome resista


       2018-05-28  1h6m

      episode 5: Myeloma Crowd Radio: HealthTree With Rafael Fonseca, MD, Mayo Clinic

      HealthTree is a new tool for multiple myeloma patients to find optimal treatment options and accelerate a cure


       2018-05-18  1h7m

      episode 4: Myeloma Crowd Radio: Luciano Costa, MD, PhD, University of Alabama

      How can newly diagnosed myeloma patients best get into remission? Here's an important study using key up-front therapies.


       2018-04-16  1h0m

      episode 3: Myeloma Crowd Radio: Veronika Bachanova, MD, PhD, University of Minnesota

      Using donor Natural Killer cells with Elotuzumab in a Myeloma Clinical Trial


       2018-03-12  51m

      episode 2: Myeloma Crowd Radio: William Matsui, MD, Johns Hopkins University

      Making allo transplant safer and more effective while also targeting precursor myeloma cells


       2018-02-16  1h10m